According to a recent LinkedIn post from ABM Respiratory Care, the company is participating in the Michigan State Respiratory Society Spring Conference in Kalamazoo, Michigan. The post highlights live, hands‑on demonstrations of its BiWaze Cough and BiWaze Clear airway clearance systems, emphasizing applications that span hospital and home care settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that conference attendees can learn about a dual blower system enabling bi‑directional control of inhalation and exhalation, as well as insights from new clinical studies on a closed breathing circuit for mucus mobilization and aerosol deposition. For investors, this visibility among respiratory therapists and clinicians may support product adoption, reinforce the BiWaze platform’s clinical positioning, and potentially contribute to future revenue growth in the respiratory care and lung health markets.
The emphasis on both in‑person demonstrations and online demo scheduling indicates a multi‑channel approach to clinician engagement. If these efforts translate into broader clinical acceptance and integration into care pathways, ABM Respiratory Care could strengthen its competitive standing in airway clearance therapy and expand its installed base across hospital and home care environments.